New urine test could spot bladder cancer without needles or scopes

NCT ID NCT07514897

Recruiting now Diagnosis Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new, non-invasive urine test that looks for a protein called CREPT in cells shed from the bladder. The goal is to see if this test can accurately detect bladder cancer and monitor if it comes back after treatment, potentially replacing uncomfortable and invasive procedures like cystoscopy. Researchers will enroll 250 people, including those with bladder cancer, benign urinary conditions, and healthy volunteers, to measure how well the test works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CREPT biomarker test (urine-based diagnostic)
What this could lead to: If successful, this could provide a simple, non-invasive urine test to catch bladder cancer early and track its return, reducing the need for invasive cystoscopies.
What could go wrong: This is an early-stage study with 250 participants, so the test may not prove accurate enough in larger, diverse populations. It is not yet a proven replacement for standard diagnostic methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Locations

National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences
RECRUITING

Beijing, Chaoyang District, 100021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.